About anteris technologies global corp - AVR
Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. It operates through the following geographical segments: United States, Germany, Australia, Switzerland, and Sweden. The company was founded in 1999 and is headquartered in Eagan, MN.
AVR At a Glance
Anteris Technologies Global Corp.
860 Blue Gentian Road
Eagan, Minnesota 55121
| Phone | 1-651-493-0606 | Revenue | 1.91M | |
| Industry | Medical Specialties | Net Income | -94,144,000.00 | |
| Sector | Health Technology | Employees | 174 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
AVR Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 96.282 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -1.884 |
| Enterprise Value to Sales | 90.818 |
| Total Debt to Enterprise Value | 0.013 |
AVR Efficiency
| Revenue/Employee | 10,994.253 |
| Income Per Employee | -541,057.471 |
| Receivables Turnover | 6.151 |
| Total Asset Turnover | 0.036 |
AVR Liquidity
| Current Ratio | 0.667 |
| Quick Ratio | 0.633 |
| Cash Ratio | 0.588 |
AVR Profitability
| Gross Margin | -16.571 |
| Operating Margin | -4,908.207 |
| Pretax Margin | -4,925.51 |
| Net Margin | -4,921.275 |
| Return on Assets | -179.15 |
| Return on Equity | -300.453 |
| Return on Total Capital | -4,300.777 |
| Return on Invested Capital | -289.616 |
AVR Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | 104.249 |
| Total Debt to Total Assets | 9.352 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 77.661 |